Trial Profile
Study developing a trastuzumab response prediction model in HER2-positive breast cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 20 Dec 2015 New trial record